Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)

CNY 15.72

(-1.63%)

EBITDA Summary of Shaanxi Kanghui Pharmaceutical Co., Ltd.

  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 3.22 Million CNY , down -0.56% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was -27.06 Million CNY , down -2309.28% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported an annual EBITDA of -31.25 Million CNY in 2022, down -53.95% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported an annual EBITDA of 60.39 Million CNY in 2021, down -5.55% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 1.22 Million CNY for 2024 Q2, down -80.34% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -27.06 Million CNY for 2024 Q3, down -2309.28% from previous quarter.

Annual EBITDA Chart of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Historical Annual EBITDA of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Year EBITDA EBITDA Growth
2023 3.22 Million CNY -0.56%
2022 -31.25 Million CNY -53.95%
2021 60.39 Million CNY -5.55%
2020 58.11 Million CNY -8.69%
2019 68.82 Million CNY -13.91%
2018 79.79 Million CNY -3.28%
2017 84.67 Million CNY -4.78%
2016 88.67 Million CNY -1.18%
2015 84.56 Million CNY 1.33%
2014 85.08 Million CNY 9.65%
2013 76.97 Million CNY 48.26%
2012 54.55 Million CNY 0.0%

Peer EBITDA Comparison of Shaanxi Kanghui Pharmaceutical Co., Ltd.

Name EBITDA EBITDA Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 99.911%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 99.176%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 99.95%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 99.685%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 99.835%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 99.716%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 99.668%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 103.557%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 99.929%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 187.88%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 99.936%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY 97.097%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 99.523%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 98.784%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 99.85%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 98.826%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 97.922%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 99.798%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 99.798%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 99.319%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 98.46%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 99.326%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 99.561%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 98.277%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 99.09%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 99.565%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 101.379%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 99.921%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 99.597%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 98.268%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 99.787%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 99.854%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 98.789%
China National Medicines Corporation Ltd. 2.82 Billion CNY 99.886%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 99.726%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 99.616%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 97.347%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -795.106%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 99.513%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY 90.624%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY 81.626%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 99.686%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 99.49%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 99.616%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 98.894%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 99.942%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 99.475%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 98.958%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 99.074%
Guobang Pharma Ltd. 1.04 Billion CNY 99.69%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 99.398%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 99.705%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 99.014%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY 97.111%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 99.429%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 105.584%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 98.711%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 99.837%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 98.347%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 99.669%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 98.413%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 98.792%
CanSino Biologics Inc. -1.64 Billion CNY 100.196%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 98.757%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 99.565%